Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 24, 440-443, April 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gitterman, C. O.
Right arrow Articles by Woodruff, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gitterman, C. O.
Right arrow Articles by Woodruff, H. B.

The Human Tumor-Egg Host System

III. Tumor-inhibitory Properties of Tenuazonic Acid*

Charles O. Gitterman, Eugene L. Dulaney, Edward A. Kaczka, George W. Campbell, David Hendlin and H. Boyd Woodruff

( Merck Sharp & Dohme Research Laboratories Division, Merck & Co., Inc., Rahway, N. J.)

The fermented broth of a culture of Alternaria tenuis auct. inhibited the growth of the human adenocarcinoma (H.Ad. #1) in the embryonated egg. With the aid of studies in the egg-tumor system the active agent was isolated and identified as tenuazonic acid. Tenuazonic acid was produced by a number of Alternaria isolated and by an Aspergillus tamarii and a Phoma sp. Compared with tenuazonic acid, on a molar basis, about 20 times as much hadacidin or 6-mercaptopurine, 2 times as much azaserine, but only 1/20 as much triethylenemelamine (TEM) were required to achieve the same inhibition of H.Ad. #1 tumor growth in the egg. Tenuazonic acid was more effective against H.Ad. #1 than against another transplantable human tumor, A-42. Tenuazonic acid, compared with puromycin, more specifically inhibited tumor growth in the egg-tumor system.

* This investigation was supported, in part, under National Institutes of Health Contract No. SA-43-pH-3057, by the Cancer Chemotherapy National Service Center, National Cancer Institute, Department of Health, Education and Welfare, U. S. Public Health Service, Bethesda, Md.

Received 9/14/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1964 by the American Association for Cancer Research.